RAPT Therapeutics, Inc.
RAPT
$0.7479
-$0.1309-14.90%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 67.76% | -188.89% | 33.37% | 9.36% | 1.15% |
| Total Depreciation and Amortization | -12.20% | -3.37% | -2.62% | -2.87% | -2.79% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.24% | 1.02% | -11.95% | 4.42% | 31.93% |
| Change in Net Operating Assets | -205.70% | 1,027.80% | 32.13% | -220.68% | -89.49% |
| Cash from Operations | -402.19% | 40.77% | 37.41% | -3.95% | 2.41% |
| Capital Expenditure | -4,200.00% | 94.12% | -1,800.00% | 100.95% | -56.72% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6,672.09% | -104.56% | -3.90% | 20.14% | -22.77% |
| Cash from Investing | -6,669.16% | -104.57% | -4.00% | 20.94% | -23.02% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -92.24% | 1,872.93% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -100.00% | -92.24% | 1,872.93% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -183.04% | 15,918.83% | 109.99% | -281.30% | 67.54% |